Aspen In Talks With African Leaders on Low Covid Vaccine Orders

Vials move along a conveyor at the Aspen Pharmacare plant in Gqeberha, South Africa.

Photographer: Waldo Swiegers/Bloomberg
Lock
This article is for subscribers only.

Aspen Pharmacare Holdings Ltd. is in talks with African leaders about how to raise demand for Covid-19 vaccines after the continent’s biggest drugmaker warned a lack of orders may force it to stop making the shots.

Discussions are “underway and I assure you it’s been elevated to the highest level on the continent,” John Nkengasong, director of Africa CDC, said at a briefing on Thursday. “I’m sure more details will be provided in coming days, once we have more details from Africa’s political leadership.”